247 related articles for article (PubMed ID: 18837963)
1. Cell-free plasma DNA during peritoneal dialysis and hemodialysis and in patients with chronic kidney disease.
Korabecna M; Opatrna S; Wirth J; Rulcova K; Eiselt J; Sefrna F; Horinek A
Ann N Y Acad Sci; 2008 Aug; 1137():296-301. PubMed ID: 18837963
[TBL] [Abstract][Full Text] [Related]
2. Plasma cell-free DNA levels in children on peritoneal dialysis.
Ozkaya O; Bek K; Bedir A; Açikgöz Y; Ozdemir T
Nephron Clin Pract; 2009; 113(4):c258-61. PubMed ID: 19684410
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
[TBL] [Abstract][Full Text] [Related]
4. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
Sjöberg B; Anderstam B; Suliman M; Alvestrand A
Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
[TBL] [Abstract][Full Text] [Related]
5. Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients.
Leinig C; Pecoits-Filho R; Nascimento MM; Gonçalves S; Riella MC; Martins C
J Ren Nutr; 2008 Sep; 18(5):424-9. PubMed ID: 18721737
[TBL] [Abstract][Full Text] [Related]
6. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
7. Oxidative modification of albumin in predialysis, hemodialysis, and peritoneal dialysis patients.
Mitrogianni Z; Barbouti A; Galaris D; Siamopoulos KC
Nephron Clin Pract; 2009; 113(3):c234-40. PubMed ID: 19690441
[TBL] [Abstract][Full Text] [Related]
8. Does a history of peritoneal dialysis result in an impaired gastrointestinal life quality?
Heine GH; Kastner CY; Jahnke T; Köhler H; Kuhlmann MK
Hemodial Int; 2007 Oct; 11(4):461-7. PubMed ID: 17922745
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.
Goi G; Massaccesi L; Baquero Herrera CJ; Musetti C; Ciurlino D; Cusi D; Bertoli S
J Nephrol; 2009; 22(5):630-6. PubMed ID: 19809996
[TBL] [Abstract][Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
11. The effects of chronic kidney disease and renal replacement therapy on circulating dendritic cells.
Hesselink DA; Betjes MG; Verkade MA; Athanassopoulos P; Baan CC; Weimar W
Nephrol Dial Transplant; 2005 Sep; 20(9):1868-73. PubMed ID: 15886215
[TBL] [Abstract][Full Text] [Related]
12. Comparison between some anthropometric measurements in adequately treated peritoneal dialysis and hemodialysis patients.
Grzebalska AM; Majdan M; Bober E; Orłowska-Kowalik G; Ksiazek A
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):20-3. PubMed ID: 16145949
[TBL] [Abstract][Full Text] [Related]
13. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
[TBL] [Abstract][Full Text] [Related]
14. Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease.
Pawlak K; Pawlak D; Mysliwiec M
Clin Biochem; 2007 Jan; 40(1-2):81-5. PubMed ID: 17046733
[TBL] [Abstract][Full Text] [Related]
15. HLA-DR expression and apoptosis: a cross-sectional controlled study in hemodialysis and peritoneal dialysis patients.
de Cal M; Cruz DN; Corradi V; Nalesso F; Polanco N; Lentini P; Brendolan A; Tetta C; Ronco C
Blood Purif; 2008; 26(3):249-54. PubMed ID: 18376106
[TBL] [Abstract][Full Text] [Related]
16. Therapy outcome in peritoneal dialysis patients transferred from haemodialysis.
Liberek T; Renke M; Skonieczny B; Kotewicz K; Kowalewska J; Chmielewski M; Kot J; Lichodziejewska-Niemierko M; Rutkowski B
Nephrol Dial Transplant; 2009 Sep; 24(9):2889-94. PubMed ID: 19342418
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis.
Cano AE; Neil AK; Kang JY; Barnabas A; Eastwood JB; Nelson SR; Hartley I; Maxwell D
Am J Gastroenterol; 2007 Sep; 102(9):1990-7. PubMed ID: 17511755
[TBL] [Abstract][Full Text] [Related]
18. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G
Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
[TBL] [Abstract][Full Text] [Related]
19. Profound mishandling of protein glycation degradation products in uremia and dialysis.
Agalou S; Ahmed N; Babaei-Jadidi R; Dawnay A; Thornalley PJ
J Am Soc Nephrol; 2005 May; 16(5):1471-85. PubMed ID: 15800128
[TBL] [Abstract][Full Text] [Related]
20. Hospitalizations in patients treated sequentially by chronic hemodialysis and continuous peritoneal dialysis.
Adeniyi M; Kassam H; Agaba EI; Sun Y; Servilla KS; Raj DS; Murata GH; Tzamaloukas AH
Adv Perit Dial; 2009; 25():72-5. PubMed ID: 19886321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
